top of page

g spot therapy

The G-SHOT® (clinical description: G-Spot Amplification™ or GSA™), is a simple, nonsurgical, nurse practitioner-administered treatment that can temporarily augment the Grafenburg spot (G-Spot) in sexually active women with normal sexual function

How is G-shot different from the O-shot?

The only difference is the product used to inject the site. Platelet-rich protein (PRP) is used instead of a synthetic filler product. The G-spot is named for Dr. Ernest Grafenberg, who first described it in a 1950 article in the International Journal of Sexology. He found a highly erogenous zone inside the vagina that gets bigger when directly stimulated and that can lead to a powerful climax.


Grafenberg’s findings were that:

An erotic zone could always be demonstrated on the anterior wall of the vagina along the course of the urethra,… [which] seems to be surrounded by erectile tissue like the corpora cavernosa [of the penis]…. In the course of sexual stimulation, the female urethra begins to enlarge and can be easily felt. It swells out greatly at the end of the orgasm. The most stimulating part is located at the posterior urethra, where it arises from the neck of the bladder:

As sex is among the more powerful forms of pleasurable stimuli known to man, researchers in the biological, anthropological, and medical fields have endeavored to discover greater knowledge of human sexuality.

This discovery can enhance sexual stimulation for women and deepen many facets of pleasure.

Is this right for you?

The G-Shot is for normal sexually functioning women. It is not for women who have sexual dysfunctions (problems with the female sexual response cycle: arousal, plateau, orgasm, resolution); relationship problems, or emotional/psychological problems. Also, patients who fit the normal criteria may experience varied to no effect at all. • In a pilot study, 87% of women (as described above) reported enhanced sexual arousal/gratification. Results can last for up to 4 months and do vary.

How does it work?

The G-Shot® is a relatively, minor office procedure performed in your clinician’s office under local anesthesia. The actual injection usually takes less than 8 seconds and the total office visit time is usually less than 30 minutes. A specially designed speculum is used to assist in the delivery of a specified amount of high molecular weight hyaluronan directly into the G-Spot after local anesthesia. The G-Shot® augments (enlarges) the G-Spot. This results in a G-Spot about the size of a quarter in width, and one-fourth of an inch in height (meaning the projection into the vagina). Note that results will vary.


What to Expect

Before you try and schedule your first G-Shot® treatment consultation, you probably have some questions, such as: How long will it take? How long will the results last? When can I resume sex?

Here’s what you might expect at the clinician’s office from the moment you arrive until your procedure is done. (Please note that although this experience is typical, the routine at your provider’s office may be different.)

On the day of your appointment allow time before your appointment for filling out forms and for consulting with the provider or a member of her staff. You may also be asked about your expectations for treatment and if you have any allergies or any condition that wouldn’t make you a good candidate for the G-Shot.


Before the Procedure

In the consultation process with Debra, ARNP, she will educate you on the G-Spot and how to localize it. Debra will go over risks and complications verbally and she will give you a written consent as well. It is important to Debra that every patient is completely informed of the risks, complications, and alternatives to the procedure (please see risk and complications). You will then go into the examination room alone and perform a self-examination based upon the instructions and after you are comfortable with the localization of the G-Spot you will notify the assistant and they will come in to start the procedure.


The Procedure

You will be positioned on the examination table as if you are “getting a PAP smear” and Debra will perform a pelvic exam and locate the coordinates of the G-Spot based upon your direction. She will transfer the coordinates to a special speculum. The speculum, which now has the location of the G-Spot on it, will then be inserted into the vagina and then a small needle will be used to deliver a small amount of local anesthetic in the area of the G-Spot. Then the high molecular weight filler will be injected. After this, a tampon is placed in the vagina (the tampon is to be removed in 4 hours). The entire G-Shot® injection procedure takes approximately 10 minutes.


After the Procedure

There’s no recovery time needed. You’re ready to get on with your day! The most common side effect following injection includes scant bleeding from the needle injection site.


Within 4 hours you can resume normal sexual activity. Results can last up to 4 months. Results will vary.


Is it safe?

G Spot Amplification™ or G-Shot has not approved the use of any of the dermal fillers by the FDA and is considered off-label use. However, collagen injection into the vagina (trans-vaginal or trans-urethral) has been performed for many years for the treatment of a condition called intrinsic sphincter deficiency (ISD) which primarily affects elderly women. In ISD the internal urethral sphincter remains open and these women continuously leak urine. These techniques are also used for the treatment of stress urinary incontinence (involuntary loss of urine with laughing, coughing, sneezing, exercising, etc).

The G-Shot procedure is an off label use. Multiple “fillers” or bio-injectables are used as bulking agents to close the internal sphincter and provide continence. There are numerous clinical investigational studies reporting on the injection of collagen substances, fillers, and bio-injectables into the vagina for conditions indicated above. The majority of the studies show that the techniques are safe and rarely have complications. Any sign of swelling, itching or redness, or other occurrences at the procedure site should be reported to your healthcare provider.

Risks not necessarily related to allergic reactions include uncomplicated urinary tract infections, urinary retention, and urethral irritation. Uncommon complications such as periurethral pseudocyst formation and urethrovaginal fistula also have been reported. Other complications seen include bleeding, infection, abscess formation, open sores, scarring, and lumpiness, which may persist over the amplification area. However, long term (> 2 years) data are lacking. Please see the consent form for a comprehensive list of the risks and complications associated with the use of this product.

It is important that every patient is informed of the risk, complications, and alternatives and therefore we have included an actual consent form that requires a patient to read it, understand it and sign it before the procedure.

bottom of page